Interim analysis of pulmonary arterial hypertension (PAH)-targeted background therapy in SPHERE (SelexiPag: tHe usErs dRug rEgistry)

V. McLaughlin (Ann Arbor, United States of America), K. Chin (Dallas, United States of America), H. Farber (Boston, United States of America), K. Highland (Cleveland, United States of America), A. Hemnes (Nashville, United States of America), M. Chakinala (St. Louis, United States of America), C. Zhao (South San Francisco, United States of America), M. Keating (South San Francisco, United States of America), N. Kim (San Diego, United States of America)

Source: International Congress 2018 – Pulmonary hypertension: therapy
Session: Pulmonary hypertension: therapy
Session type: Thematic Poster
Number: 3043
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. McLaughlin (Ann Arbor, United States of America), K. Chin (Dallas, United States of America), H. Farber (Boston, United States of America), K. Highland (Cleveland, United States of America), A. Hemnes (Nashville, United States of America), M. Chakinala (St. Louis, United States of America), C. Zhao (South San Francisco, United States of America), M. Keating (South San Francisco, United States of America), N. Kim (San Diego, United States of America). Interim analysis of pulmonary arterial hypertension (PAH)-targeted background therapy in SPHERE (SelexiPag: tHe usErs dRug rEgistry). 3043

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: